ClinicalTrialsFinder

Postural Orthostatic Tachycardia Syndrome (POTS) Clinical Trials in New York, New York

1 recruitingNew York, New York

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

Postural Orthostatic Tachycardia Syndrome (POTS)
Regeneron Pharmaceuticals81 enrolled18 locationsNCT06593600